Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Technology Update.
Press releases published on August 14, 2025
ARRAY Technologies Completes Acquisition of APA Solar
ALBUQUERQUE, N.M., Aug. 14, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software, and services for utility-scale solar energy projects, today …
Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights
Announced CNSide® CSF assay platform launch timeline Initiated the REYOBIQ dose optimization trial for patients with leptomeningeal metastases HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a …
Microchip Technology to Webcast Annual Meeting of Shareholders
CHANDLER, Ariz., Aug. 14, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that it will webcast its Annual Meeting of Shareholders …
Duos Technologies Group Reports Second Quarter 2025 Results
JACKSONVILLE, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions and operational services for the deployment …
Updated time: HP Inc. to Announce Third Quarter Fiscal 2025 Earnings on Aug 27, 2025
PALO ALTO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) will present a live audio webcast of a conference call to review financial results for the third fiscal quarter ended July 31, 2025 on Wednesday, Aug 27, 2025 at 4:30 p.m. ET / 1:30 p …
Shuttle Pharma Provides Second Quarter 2025 Corporate Update
GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of …
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Next-generation claudin 18.2 ISAC BDC-4182 now in Phase 1 dose-escalation study Cash balance of $48.5 million as of June 30, 2025 anticipated to fund key milestones through mid-2026 REDWOOD CITY, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bolt …
GT Biopharma Reports Second Quarter 2025 Financial Results
GTB-3650 TriKE® Phase 1 trial has successfully completed Cohort 1 and Cohort 2 dosing, treating a total of four patients; following Cohort 2’s formal safety review, it has advanced into Cohort 3 and initiated dosing of the fifth patient in the study; …
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
– Phase 1 monotherapy expansion study of micvotabart pelidotin (MICVO) for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients progressing well with preliminary data in second half of 2025 and first half of 2026 – Phase 1/ …
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
Presented positive translational data from SYNGAP1-related disorders program showcasing efficacy in a humanized SYNGAP mouse model and increased protein in non-human primates at the 28th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting …
Magnite to Participate in Upcoming Financial Conferences
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host investor meetings at the following financial conferences …
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Trust Stamp files its 2025 Q2 10-Q and announced continued growth in OL Platform Registrations and a Key Performance Metric
Atlanta, GA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) announced that: It filed its Q2 10-Q report for the six months ended 30 June 2025 after the Nasdaq market closed on August 14th, 2025. Net recognised revenue for the three months …
Nasus Pharma Announces Closing of Initial Public Offering
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …
authID Reports Financial and Operating Results for the Second Quarter 2025; Delivers the Highest Revenue in the Company’s History
DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the second quarter ended …
IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights
Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed; company plans to meet …
Banzai Reports Second Quarter 2025 Financial Results
Revenue of $3.3 Million for Q2 2025, Representing 205% Growth from Q2 2024 Gross Profit of $2.7 Million for Q2 2025, Representing 267% Growth from Q2 2024; Gross Margin Expanded to 83.0% in Q2 2025 a 1390 BPS Increase Management to Host Second Quarter 2025 …
Intchains Group Limited Reports Second Quarter and First Half 2025 Financial Results
Reinforces its Leading ETH Treasury Position: Increased ETH holdings to 8,816 as of June 30, 2025, up 26% from March 31, 2025, and 55% from December 31, 2024 Updates on Its Long-Term Dollar-Cost Averaging ETH Treasury Strategy Designed to Boost Overall …